BUCHAN JANE
SEC insider (Form 3/4/5 filer). CIK 0001342502. Director at Immix Biopharma, Inc. (IMMX). 2 reported Form 4/5 transactions since Sep 2024; latest on May 22, 2026. Located in LOS ANGELES, CA.
Companies BUCHAN JANE has filed insider reports for
- Immix Biopharma, Inc. (IMMX): Director
BUCHAN JANE
CIK: 0001342502
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMMX
Immix Biopharma, Inc.
Director